Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphoma

被引：0
|
作者：
Houot, Roch [1 ,2 ]
Armand, Philippe [1 ,2 ]
Jacobson, Caron A. [1 ,2 ]
机构：
[1] Univ Rennes, CHU Rennes, Dept Hematol, INSERM,EFS,U1236, Rennes, France
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 131卷
关键词：
IBRUTINIB; OUTCOMES;
D O I：
10.1016/j.ejca.2020.03.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [31] Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma
    Zhou, Wenyujing
    Chen, Weihong
    Wan, Xiaochun
    Luo, Changru
    Du, Xin
    Li, Xiaoqing
    Chen, Qian
    Gao, Ruiwen
    Zhang, Xiaohan
    Xie, Mei
    Wang, Mingjun
    FRONTIERS IN GENETICS, 2022, 12
  • [32] Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma
    Messerli, Christian
    Wiedemann, Gertrud
    Porret, Naomi
    Nagler, Michael
    Seipel, Katja
    Jeker, Barbara
    Novak, Urban
    Zeerleder, Sacha
    Bacher, Ulrike
    Pabst, Thomas
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 187 - 196
  • [33] Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report
    Chen, Hsin-Hui
    Kuo, Cheng-Yi
    Ho, Ching-Liang
    Chen, Yeu-Chin
    MEDICINE, 2023, 102 (41) : E35432
  • [34] Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma
    Hu, Yongxian
    Zheng, Weiyan
    Qiao, Jianjun
    Cui, Qu
    Zhu, Yuanyuan
    Chang, Alex H.
    Huang, He
    JAMA DERMATOLOGY, 2020, 156 (09) : 1026 - 1028
  • [35] B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
    Young, Ryan M.
    Shaffer, Arthur L., III
    Phelan, James D.
    Staudt, Louis M.
    SEMINARS IN HEMATOLOGY, 2015, 52 (02) : 77 - 85
  • [36] Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience
    Schaefer, Andrew
    Huang, Ying
    Kittai, Adam
    Maakaron, Joseph E.
    Saygin, Caner
    Brammer, Jonathan
    Penza, Sam
    Saad, Ayman
    Jaglowski, Samantha M.
    William, Basem M.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8901 - 8906
  • [37] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [38] Salvage Radiation Treatment for Primary Refractory Diffuse Large B-cell Lymphoma After Chimeric Antigen Receptor (CAR) T-cell Therapy: A Case Report
    Wang, Kaidi
    Prabhu, Arpan V.
    Sasapu, Appalanaidu
    Lewis, Gary D.
    ANTICANCER RESEARCH, 2021, 41 (07) : 3635 - 3638
  • [39] Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma
    Seyedin, Roxanna
    Snider, Julia T.
    Rajagopalan, Krithika
    Wade, Sally W.
    Gergis, Usama
    FUTURE ONCOLOGY, 2023, 19 (22) : 1535 - 1547
  • [40] ROLE OF CAR-T CELLS THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
    Sen, P.
    Saadeh, B.
    Loh, E.
    VALUE IN HEALTH, 2019, 22 : S440 - S441
12345